| Literature DB >> 35090430 |
Leonard Banza Ngoie1,2,3, Eva Dybvik4, Geir Hallan5,6, Jan-Erik Gjertsen5,7, Nyengo Mkandawire8,9, Carlos Varela10,5,8, Sven Young10,7,8.
Abstract
BACKGROUND: More than a billion people globally are living with disability and the prevalence is likely to increase rapidly in the coming years in low- and middle-income countries (LMICs). The vast majority of those living with disability are children residing in LMICs. There is very little reliable data on the epidemiology of musculoskeletal impairments (MSIs) in children and even less is available for Malawi. Previous studies in Malawi on childhood disability and the impact of musculoskeletal impairment (MSI) on the lives of children have been done but on a small scale and have not used disability measurement tools designed for children. Therefore in this study, we aimed to estimate the MSI prevalence, causes, and the treatment need among children aged 16 years or less in Malawi.Entities:
Keywords: Childhood disability; Cluster randomized survey; Malawi; Musculoskeletal impairment
Mesh:
Year: 2022 PMID: 35090430 PMCID: PMC8796456 DOI: 10.1186/s12887-022-03113-8
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Standardized interview and examination protocol
| Elements | Definition |
|---|---|
| Diagnosis categorized as: neurological, traumatic, congenital, metabolic, infective, or acquired non-traumatic non-infective. Within these categories an algorithm was created and used to give a specific diagnosis. Up to two diagnoses were permissible per each identified case of MSI [ | |
| Severity was determined using ICF parameters for the amount of function which was lost through the presence of the impairment. This was classified as “mild”, “moderate” or “severe” [ | |
| Any known treatment given to the participant (medical or other) was recorded | |
| Treatment required by the participants was assessed according to Malawi standard treatment guideline. |
Baseline table for the 3648 children
| Total ( | MSI ( | No MSI ( | ||
|---|---|---|---|---|
| Gender | 0.046* | |||
| Male | 1917 | 137 (7%) | 1780 (93%) | |
| Female | 1731 | 99 (6%) | 1632 (94%) | |
| Age | 0.56 | |||
| 0–5 yr | 1109 | 76 (7%) | 1033 (93%) | |
| 5–16 yr | 2539 | 160 (6%) | 2379 (94%) | |
| Location | 0.36 | |||
| Rural | 3270 | 25 (6.5%) | 3245 (93.5%) | |
| Urban | 151 | 11 (7%) | 140 (93%) | |
| Missing | 27 | 0 (0%) | 27 (100%) | |
| Parents educational level | 0.005 | |||
| None | 1073 | 94 (9%) | 979 (91%) | |
| Primary | 2240 | 127 (6%) | 2113 (94%) | |
| Secondary | 260 | 10 (4%) | 250 (96%) | |
| University | 25 | 2 (8%) | 23 (92%) | |
| Missing | 50 | 3 (6%) | 47 (94%) | |
| Severity MSI** | ||||
| Mild | 55 | 55 (23.3%) * | 0 | |
| Moderate | 112 | 112 (47.5%) * | 0 | |
| Severe | 69 | 69 (29.2%) * | 0 | |
| Missing | 3412 | 0 | 3412 | |
*Percent of the 236 MSI cases
**According to the WHO International Classification of Function
MSI Diagnosis and Extrapolation to Malawi population
| Diagnosis | Number | Total in category (%) | Extrapolated number of that diagnosis in Malawi to nearest 1000 (95% CI) |
|---|---|---|---|
| 165 (46%) | 403,000 (343,000–463,000) | ||
| Syndactyly | 13 | 32,000 (15,000-49,000) | |
| Polydactyly | 29 | 71,000 (45,000-96,000) | |
| Other UL deformity | 19 | 46,000 (26,000-67,000) | |
| Club foot | 19 | 46,000 (26,000-67,000) | |
| Other LL deformity | 28 | 68,000 (43,000-94,000) | |
| Spine deformity | 43 | 105,000 (74,000-136,000) | |
| Other congenital deformity | 14 | 34,000 (16,000-52,000) | |
| 30 (8.4%) | 73,000 (47,000-99,000) | ||
| Burn contracture | 6 | 15,000 (3000-26,000) | |
| Fracture non/ malunion | 7 | 17,000 (4000-30,000) | |
| Spine injury | 0 | ||
| Head injury | 2 | 5000 (0–12,000) | |
| Tendon/nerve injury | 6 | 15,000 (3000-26,000) | |
| Amputation | 5 | 12,000 (2000-23,000) | |
| Joint chronic dislocation | 4 | 10,000 (0–19,000) | |
| Other chronic joint injury | 0 | ||
| 123 (34.4%) | 300,000 (248,000-353,000) | ||
| Epilepsy | 43 | 105,000 (74,000-136,000) | |
| Polio (sequelae) | 11 | 27,000 (11,000-43,000) | |
| Para/quadra/Hemiplegia | 15 | 37,000 (18,000-55,000) | |
| Cerebral palsy | 46 | 112,000 (80,000-145,000) | |
| Peripheral nerve palsy | 0 | ||
| Other neurological MSI | 8 | 20,000 (6000-33,000) | |
| 12 (3.4%) | 30,000 (13,000-46,000) | ||
| Bone infection limb | 2 | 5000 (0–12,000) | |
| Joint infection | 3 | 7000 (0–16,000) | |
| Spine infection | 2 | 5000 (0–12,000) | |
| Soft tissue infection | 5 | 12,000 (2000-23,000) | |
| 28 (7.8%) | 68,000 (43,000-94,000) | ||
| Angular limb deformity | 11 | 27,000 (11,000-43,000) | |
| Joint problem | 3 | 7000 (0–16,000) | |
| Spine pain | 0 | ||
| Skin/ soft tissue/ bone swelling | 2 | 5000 (0–12,000) | |
| Limb swelling | 11 | 27,000 (11,000-43,000) | |
| Limb pain | 0 | ||
| Other acquired spine deformity | 1 | 403,000 (343,000–463,000) | |
LL Lower limbs, UL Upper Limbs
Fig. 1The extrapolated need of treatment for MSI in children in the Malawi population. P&O: Prosthesis and Orthosis